<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined 11 cases of <z:mp ids='MP_0002038'>carcinoma</z:mp> arising from <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> consisting of two <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> in situ (ACIS), two intramucosal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, and seven overt invasive <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Overexpression of p53 (implying a mutation of the p53 gene), ERBB2, and EGFR was measured by immunohistochemistry, and gene amplification of ERBB2 and EGFR was measured by fluorescence in situ hybridization (FISH) </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases of ACIS and the intramucosal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, almost <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells overexpressed p53, however the populations overexpressing ERBB2 and EGFR varied in different cases: in one ACIS, ERBB2 was coexpressed in <z:hpo ids='HP_0000001'>all</z:hpo> the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, in the other ACIS and one intramucosal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, ERBB2 was overexpressed in about 50% and only 10% of the p53-positive cells respectively </plain></SENT>
<SENT sid="3" pm="."><plain>EGFR was co-expressed in 20% in the other intramucosal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>Protein overexpression of ERBB2 or EGFR corresponded to the amplification of their respective genes on a cell by cell basis </plain></SENT>
<SENT sid="5" pm="."><plain>These gene amplifications, however, were not found in the seven invasive <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Thus we speculate that the gene amplification occurred late in the <z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence probably after the mutation of p53 </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, new clonal expansion accompanied by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion might have extinguished the originally amplified genes in these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>